High Tech Pharm Co Ltd banner
H

High Tech Pharm Co Ltd
KOSDAQ:106190

Watchlist Manager
High Tech Pharm Co Ltd
KOSDAQ:106190
Watchlist
Price: 19 340 KRW 25.42% Market Closed
Market Cap: ₩205.6B

Balance Sheet

Balance Sheet Decomposition
High Tech Pharm Co Ltd

Balance Sheet
High Tech Pharm Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
89
548
1 205
1 834
944
558
1 134
6 202
4 759
9 658
22 486
17 846
20 804
22 956
10 074
3 007
3 965
3 108
1 038
11 275
7 880
3 483
7 759
13 076
Cash
0
0
0
0
0
0
0
0
0
5
7
8
13
8
9
5
7
3
5
3
6
3 483
7 759
13 076
Cash Equivalents
89
548
1 205
1 834
944
558
1 134
6 202
4 759
9 653
22 479
17 838
20 791
22 948
10 065
3 002
3 958
3 105
1 033
11 271
7 875
0
0
0
Short-Term Investments
1 416
11
4
4
0
0
0
0
20 932
19 645
17 000
21 500
22 535
9 923
0
0
0
7 222
0
1 363
0
1 882
0
1 354
Total Receivables
2 294
3 182
3 490
3 927
5 377
9 957
10 731
15 421
23 216
26 405
14 397
18 432
17 963
13 127
19 388
19 307
17 976
17 875
19 708
9 472
28 555
24 483
20 357
11 354
Accounts Receivables
1 953
2 877
3 305
3 749
5 374
9 956
10 719
15 414
23 199
26 368
14 224
18 252
17 677
13 079
19 211
19 161
17 899
17 444
19 564
9 413
28 476
24 443
20 333
11 329
Other Receivables
341
305
185
178
3
1
12
7
17
37
173
180
286
48
177
146
77
431
144
59
78
40
25
25
Inventory
801
3 746
2 102
1 019
1 547
3 179
5 624
7 302
11 559
10 519
5 188
8 753
7 773
10 223
10 239
8 170
10 929
9 884
18 632
17 708
14 676
25 498
34 813
43 727
Other Current Assets
194
393
294
247
1 138
504
887
696
888
765
644
832
1 908
1 335
1 793
681
792
934
1 099
672
929
1 225
1 305
1 480
Total Current Assets
4 794
7 879
7 095
7 031
9 005
14 198
18 376
29 621
61 354
66 993
59 714
67 363
70 983
57 563
41 494
31 165
33 662
39 024
40 477
40 488
52 040
56 571
64 234
70 991
PP&E Net
2 523
2 824
2 741
3 057
5 648
5 594
5 636
5 388
14 240
14 370
23 955
23 737
32 202
50 525
72 782
83 440
93 232
89 944
85 205
80 544
74 934
75 001
72 002
68 854
PP&E Gross
2 523
2 824
2 741
3 057
5 648
5 594
5 636
5 388
14 240
14 370
23 955
23 737
32 202
50 525
72 782
83 440
93 232
89 944
85 205
80 544
74 934
75 001
72 002
68 854
Accumulated Depreciation
1 947
2 219
2 477
2 719
2 924
3 033
4 096
5 020
4 883
5 917
7 070
8 074
8 980
9 793
10 461
11 014
11 518
17 027
22 486
27 997
32 958
37 896
42 983
48 299
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14
0
0
0
Long-Term Investments
45
61
4
4
7
43
169
345
564
0
0
3 303
3 243
3 079
3 425
3 527
4 898
1 718
2 468
1 768
2 198
2 046
3 061
2 451
Other Long-Term Assets
18
54
54
125
141
137
155
191
134
928
1 174
1 165
167
263
608
966
1 205
1 038
297
136
3 016
1 440
793
1 400
Total Assets
7 380
N/A
10 819
+47%
9 894
-9%
10 217
+3%
14 801
+45%
19 972
+35%
24 336
+22%
35 545
+46%
76 292
+115%
82 290
+8%
84 843
+3%
95 568
+13%
106 595
+12%
111 430
+5%
118 310
+6%
119 098
+1%
132 998
+12%
131 725
-1%
128 446
-2%
122 937
-4%
132 202
+8%
135 058
+2%
140 090
+4%
143 697
+3%
Liabilities
Accounts Payable
1 894
3 418
2 381
2 647
3 223
7 288
4 240
9 260
12 275
9 253
5 066
6 787
7 536
10 544
13 730
13 348
13 977
17 017
16 824
10 451
13 130
8 692
5 348
6 628
Accrued Liabilities
40
39
35
98
186
168
167
175
222
203
189
282
87
303
434
470
550
701
821
608
633
1 203
1 177
769
Short-Term Debt
0
1 239
854
849
3 720
1 208
1 419
1 000
0
0
0
0
2 616
0
0
0
5 000
5 000
5 000
10 000
10 000
11 447
7 940
0
Current Portion of Long-Term Debt
1 801
599
626
0
0
0
4 389
0
0
0
0
0
0
0
0
702
0
4
2
2
6 360
27
28
22
Other Current Liabilities
62
147
245
281
352
489
1 459
2 238
2 800
1 970
2 434
2 489
2 994
2 478
1 729
1 759
5 483
2 833
4 285
1 642
1 615
1 416
4 453
5 100
Total Current Liabilities
3 797
5 443
4 142
3 875
7 480
9 153
11 674
12 673
15 297
11 427
7 689
9 557
13 233
13 324
15 893
16 279
25 010
25 554
26 933
22 703
31 738
22 785
18 946
12 519
Long-Term Debt
240
1 198
939
912
837
2 844
0
850
0
0
0
0
624
648
674
0
2 236
5 811
5 481
5 975
64
5 026
34
12
Deferred Income Tax
0
0
0
0
0
0
0
0
487
228
58
9
286
64
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
13
20
2
53
107
97
36
130
271
32
174
388
189
565
626
2 405
1 776
888
374
461
253
1 372
494
Total Liabilities
4 037
N/A
6 654
+65%
5 101
-23%
4 789
-6%
8 370
+75%
12 105
+45%
11 771
-3%
13 559
+15%
15 915
+17%
11 925
-25%
7 779
-35%
9 740
+25%
14 531
+49%
14 225
-2%
17 133
+20%
16 904
-1%
29 651
+75%
33 141
+12%
33 302
+0%
29 052
-13%
32 263
+11%
28 064
-13%
20 352
-27%
13 025
-36%
Equity
Common Stock
4 255
4 255
4 255
4 255
4 255
4 255
4 255
2 450
3 544
3 544
3 544
3 544
3 544
3 544
3 544
3 544
3 544
3 544
3 544
3 544
3 544
3 544
5 317
5 317
Retained Earnings
894
72
556
1 191
2 194
3 613
8 311
17 622
31 765
41 753
48 452
57 442
63 420
68 413
72 604
73 606
74 734
69 972
66 532
65 273
71 327
78 382
91 138
102 071
Additional Paid In Capital
0
0
0
0
0
0
0
1 915
25 068
25 068
25 068
25 068
25 068
25 068
25 068
25 068
25 068
25 068
25 068
25 068
25 068
25 068
23 290
23 290
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
226
0
180
39
25
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
Other Equity
18
18
18
18
18
0
0
0
0
0
0
0
32
0
0
0
0
0
0
0
0
0
0
0
Total Equity
3 342
N/A
4 164
+25%
4 793
+15%
5 427
+13%
6 431
+19%
7 868
+22%
12 566
+60%
21 986
+75%
60 377
+175%
70 365
+17%
77 064
+10%
85 828
+11%
92 064
+7%
97 205
+6%
101 178
+4%
102 194
+1%
103 347
+1%
98 584
-5%
95 144
-3%
93 885
-1%
99 939
+6%
106 994
+7%
119 738
+12%
130 671
+9%
Total Liabilities & Equity
7 380
N/A
10 819
+47%
9 894
-9%
10 217
+3%
14 801
+45%
19 972
+35%
24 336
+22%
35 545
+46%
76 292
+115%
82 290
+8%
84 843
+3%
95 568
+13%
106 595
+12%
111 430
+5%
118 310
+6%
119 098
+1%
132 998
+12%
131 725
-1%
128 446
-2%
122 937
-4%
132 202
+8%
135 058
+2%
140 090
+4%
143 697
+3%
Shares Outstanding
Common Shares Outstanding
5
5
5
5
5
5
5
5
7
7
7
7
7
7
7
7
7
7
7
11
11
11
11
11
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett